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pdx1 (pancreatic and duodenal homeobox gene-1), which is expressed broadly in the embryonic pancreas and, later, in a
more restricted manner in the mature b cells in the islets of Langerhans, is essential both for organ formation and b cell gene
expression and function. We carried out a transgenic reporter gene analysis to identify region- and cell type-specific
regulatory regions in pdx1. A 14.5-kb pdx1 genomic fragment corrected the glucose intolerance of pdx11/2 animals but,
oreover, fully rescued the severe gut and pancreas defects in pdx12/2 embryos. Sequences sufficient to direct reporter
expression to the entire endogenous pdx1 expression domain lie within 4.3 kb of 5* flanking DNA. In this region, we
identified two distinct fragments that drive reporter gene expression to different sets of islet neuroendocrine cells. One
shows pan-endocrine cell specificity, the other is selectively activated in insulin-producing b cells. The endocrine-specific
regulatory regions overlap a localized region of 5* flanking DNA that is remarkably conserved in sequence between
vertebrate pdx1 genes, and which has been associated with b cell-selective expression in cultured cell lines. This region
contains potential binding sites for several transcription factors implicated in endodermal development and the pathogen-
esis of some forms of type-2 diabetes. These results are consistent with our previous proposal that conserved upstream pdx1
sequences exert control over pdx1 during embryonic organogenesis and islet endocrine cell differentiation. We propose that
mutations affecting the expression and/or activity of transcription factors operating via these sequences may predispose
towards diabetes, at least in part by direct effects on endocrine pdx1 expression. © 2001 Academic Press
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Organogenesis involves multiple interactions among in-
terdependent cell types and, concomitantly, the precise
orchestration of cellular differentiation programs by com-
plex batteries of transcription factors. Many genes have
been linked to the differentiation of specific embryonic cell
types. There are fewer examples where the development of
a whole organ is affected by single gene mutations, includ-
ing the spleen, which requires Hox11 (Roberts et al., 1994),
and the pancreas, which requires both pdx1 and PTFp48
(Jonsson et al., 1994; Offield et al., 1996; Krapp et al., 1998).
The pancreas develops from separate dorsal and ventral
utgrowths of the endodermal epithelium, which later fuse.
1 Present address: Genetics Institute, 87 Cambridge Park Drive,
Cambridge, MA 02140
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All rights of reproduction in any form reserved.orsal bud outgrowth depends on inductive signals from
he nearby notochord (Kim et al., 1997; Hebrok et al., 1998),
nd its subsequent expansion and differentiation require
ontinuous signals from the surrounding mesenchyme
Wessels et al., 1967; Ahlgren et al., 1996). Gene-
nactivation studies reveal that dorsal and ventral bud
evelopment occur independently and require different sets
f transcription factors. For example, mutations in Isl1 or
lxb9 block dorsal, but not ventral, bud outgrowth (Ahl-
ren et al., 1997; Li et al., 1999; Harrison et al., 1999).
orphogenesis of the pancreatic epithelium yields a highly
ranched ductal network within which multipotent precur-
ors give rise to both exocrine and endocrine cells in a
rocess involving cell–cell interactions and Notch signal-
ng (Apelqvist et al., 1999; Jensen et al., 2000; Schwitzgebel
t al., 2000). The exocrine (acinar) cells produce digestive
nzymes. Endocrine cells located within the islets of Lang-
rhans produce peptide hormones involved in glucose
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186 Gannon, Gamer, and Wrighthomeostasis—glucagon, insulin, somatostatin, and pancre-
atic polypeptide—in a, b, d, and PP cells, respectively. As
for other organs of the digestive system, a substantial
amount of pancreas differentiation and morphogenesis oc-
curs after birth, with the exocrine and endocrine compart-
ments becoming fully functional by weaning (Lebenthal
and Lebenthal, 1999; Menard et al., 1994). Consequently,
while mutations in genes that affect the differentiation of
specific pancreatic cell types may have dramatic embryonic
phenotypes, some of their effects may not be manifested
physiologically until the neonatal period or even into adult-
hood.
Our laboratory focuses on pdx1 (pancreas and duodenum
homeobox gene 1), which may represent a nodal point in a
network of transcriptional regulators that directs pancreas
formation, maintenance, and function. In all vertebrates
examined, pdx1 is expressed in the region of the endoderm
that ultimately gives rise to stomach, pancreas, and duode-
num (Gannon and Wright, 1999) and its function is critical
for posterior foregut development. Null mutations in pdx1
FIG. 1. Diagram of pdx1 locus showing relevant restriction enzym
black box, homeodomain. Transgenic constructs are named accordi
in parentheses indicate number of expressing lines (numerator) o
transgene is given at the right. B, BstEII; Bg, BglII; P, PstI; RV, Ecoresult in defects in most, if not all, of the different cell types
Copyright © 2001 by Academic Press. All rightn which it is expressed, including malformations of the
ylorus and rostral duodenum, absence of Brunner’s glands,
nd reduced numbers of specific enteroendocrine cell types
n the stomach and intestine (Jonsson et al., 1994; Offield et
l., 1996; Larsson et al., 1996). Most dramatically, loss of
dx1 function results in pancreatic agenesis in mice and
umans (Jonsson et al., 1994; Offield et al., 1996; Stoffers et
l., 1997b).
Late aspects of pancreatic differentiation and maintenance
f mature organ function also require pdx1. Tissue-specific
ene-inactivation experiments show that deletion of pdx1
unction from b cells causes dramatic decreases in insulin
xpression and overt diabetes (Ahlgren et al., 1998; M.G. and
.V.E.W., unpublished observations). In addition to the insu-
in gene, PDX1 can activate transcription of several genes
nvolved in glucose sensing and metabolism such as GLUT2
nd glucokinase (Watada et al., 1996a,b; Waeber et al., 1996;
Wu et al., 1999; MacFarlane et al., 2000b; Sayo et al., 2000;
Glick et al., 2000). pdx11/2 mice are glucose intolerant (Dutta
t al., 1998; Ahlgren et al., 1998), suggesting that gene dosage
tes. Thin lines, pdx1 genomic sequences; gray boxes, pdx1 exons;
restriction enzyme sites and are drawn below the locus. Numbers
total lines examined (denominator). Expression pattern for each
S, SmaI; Sc, SacI; Sp, SpeI; X, XbaI; Xh, XhoI.e si
ng to
ut ofis critical for maintaining normal blood glucose levels. Con-
s of reproduction in any form reserved.
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187Transgenic Analysis of pdx1 Regulationsistent with this, humans heterozygous for inactivating mu-
tations of pdx1 are predisposed to diabetes (Stoffers et al.,
FIG. 2. A pdx1 transgene rescues pancreatic development in pdx1
and L2 (G, H) neonates. pdx1-driven lacZ expression from the pdx1
copies of the pdx1lacZKO null allele results in darker X-gal staining in
issue magnified in (B) and (E), respectively. Islets are present along
mmunolabelled for glucagon (brown) to outline islets. (G, H) Two
, stomach; sp, spleen; d, duodenum; dd, dorsal ductile; p, pancrea998) and other mutations in human pdx1 (Ipf1) are associated S
Copyright © 2001 by Academic Press. All rightith adult onset (Type II) diabetes (Macfarlane et al., 2000a)
nd maturity onset diabetes of the young type 4 (MODY4;
ice. Digestive organs from pdx11/2 (A), and pdx12/2;pdx1resc L1 (D)
null allele is detected by X-gal staining (blue). The presence of two
12/2;pdx1resc animals. Boxed areas in (A) and (D) indicate pancreatic
ancreatic duct (arrowheads in C and F). Sections in (C) and (F) were
ples of the extent of pancreatic rescue observed in L2 transgenics.
D: 3.753; B, E, G, H: 123; C, F: 253.2/2 m
lacZKO
pdxtoffers et al., 1997a).
s of reproduction in any form reserved.
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188 Gannon, Gamer, and WrightIn addition to pdx1, mutations in other homeobox genes
(Isl1, Pax4 and -6, Nkx2.2, Hlxb9, HNF6), or genes encoding
basic helix–loop–helix proteins (Beta2/NeuroD, PTF1p48,
neurogenin3), abrogate pancreatic development, or cause
loss of or dramatic reduction in specific pancreatic cell
types (Ahlgren et al., 1997; Sosa-Pineda et al., 1997; St-Onge
t al., 1997; Naya et al., 1997; Krapp et al., 1998; Sussel et
l., 1998; Harrison et al., 1999; Li et al., 1999; Jacquemin et
l., 2000; Gradwohl et al., 2000). Mutations in other
endodermal transcription factors are also associated with
subtypes of human diabetes, for example, HNF1a
(MODY3), HNF1b, (MODY5), and HNF4a (MODY1)
Yamagata et al., 1996a,b; Horikawa et al., 1997).
The evolutionarily conserved expression pattern and
unction of pdx1 make it an attractive entry point for
ddressing the general issue of endodermal regionalization
nd the mechanisms driving pancreas outgrowth. Within
he posterior foregut, the anterior limit of pdx1 expression
n the stomach is sharp, but the posterior boundary within
he duodenum is much less definite. pdx1 expression
ithin the pancreas itself is dynamic. Initially it is detected
hroughout the epithelium, but becomes downregulated in
xocrine and ductal tissue, although cells within the ductal
pithelium are capable of reactivating pdx1 during pancre-
tic regeneration and islet neogenesis (Song et al., 1999;
harma et al., 1999). In neonates and adults, pdx1 expres-
ion is highest in insulin-producing b cells with lower
levels in subpopulations of acinar cells (Guz et al., 1995;
Wu et al., 1997). Little is known about the processes that
regulate pdx1 expression along the anteroposterior axis of
the primitive gut, during organogenesis, or during the
differentiation, maintenance, and function of specific cell
types. We have used a transgenic reporter gene assay to
identify regulatory regions that drive pdx1 expression in
distinct patterns during embryonic development and in the
adult organ. Our data suggest that separate regulatory
modules direct duodenal versus pancreatic expression, and
that multiple elements contribute to the complex spatio-
temporal expression pattern of pdx1 within the islet endo-
crine cells.
MATERIALS AND METHODS
pdx1 Transgenic Constructs and Generation of
Transgenic Mice
(See Fig. 1 for location of restriction enzyme sites.) pdx1resc was
generated by using an approximately 14.5-kb lambda genomic
clone (Offield et al., 1996). The SalI site is located within the
ambda vector. Construction of XSlacZPS, XSlacZ, and PBhsplacZ has
een previously described (Wu et al., 1997). All constructs desig-
ated “hsp.lacZ” contain pdx1 promoter fragments blunt-end
igated into the SmaI site of the modified hsp68lacZpA vector (a
ift from B. Hogan; Sasaki and Hogan, 1996), which contains the
eat shock protein minimal promoter and a bacterial lacZ cDNA.
hsplacZ hsplacZXSc , 4.3 kb 59 XbaI to 59 SacI; XXh , 2.5 kb 59 XbaI to XhoI;
XhSchsplacZ, 1.8 kb XhoI to SacI; SphsplacZ, 3.0 kb SpeI site within 39
p
d
Copyright © 2001 by Academic Press. All rightUTR to SalI; XPhsplacZ, 1.6 kb 59 XbaI to PstI; XhBghsplacZ, 1.1 kb XhoI
to BglII; BgSchsplacZ, 690 bp BglII to SacI.
Other genomic fragments were generated by PCR. Lower-case
nucleotides indicate base changes introduced to produce 59
HindIII or 39 PstI restriction enzyme sites for directional cloning
into the hsplacZ vector. PCR products were sequenced to ensure
fidelity of amplification. 59XhBghsplacZ, 360 bp, F, 59-GG-
TGaaGCTtGAGGAACAGCAGGGGGTC-3 9 ; R, 5 9 -GT-
TCTGcagTCTTCAGGGAAAAGAGCCAC-39. 39XhBghsplacZ,
720 bp, F, 59-CAGGaaGCTtTTTTCCCTGAAGAAATCAGAG-
39; R, 59-GGGTcTgCAGATCTGTGACCATCCTGGCGTC-39. 39Xh-
SchsplacZ , 1.4 kb, F, forward primer of 39XhBghsplacZ , R, 59-
CTTGCTGCaGTGGAGCTCTCCAAAACG-39.
Plasmid DNA was CsCl-purified; the insert isolated by low-melt
agarose gel electrophoresis following SalI digestion, and purified
using Gelase (Epicentre Technologies). Pronuclei of one-cell em-
bryos from B6D2 females were injected with 1–5 pl DNA (3 ng/ml)
and embryos implanted into psuedopregnant ICR females (Hogan,
1994). Some F0 founders were sacrificed at embryonic stages to
analyze the pdx1-driven b-galactosidase (b-gal) expression pattern,
although transgenic lines were generated for most constructs.
Genotyping was by Southern blot analysis of DNA isolated from
brain (embryos and neonates) or tail (adults) tissue. pdx11/2 mice
ere identified as in Offield et al. (1996). pdx1resc animals were
identified by probing PstI and SalI digested DNA with a 550-bp
XbaI–EcoRI 39 fragment from the pdx-1 locus (Offield et al., 1996).
hsplacZ transgenics were identified by probing PvuII-digested
DNA with a 726-bp PvuI fragment from lacZ. To determine
transgene copy number, hybridization of 10 mg digested genomic
DNA with the appropriate probe was compared with known copy
number equivalents of the parent transgene plasmid run in parallel.
Characterization of Transgenics
The morning of vaginal plug was considered 0.5 d.p.c. Dissected
internal organs were fixed, embedded, sectioned, and stained with
X-gal to detect b-gal enzymatic activity as described (Wu et al.,
997; Gannon et al., 2000b). Immunoperoxidase staining for insu-
in, glucagon, somatostatin, and GLUT2 was performed as previ-
usly described (Gannon et al., 2000b). Rabbit anti-amylase anti-
ody (a gift from Ray MacDonald) was used at 1:500.
holecystokinin (CCK), secretin (Peninsula Labs), and serotonin
Dako) were used at 1:2000, 1:1000, and 1:1000, respectively.
lucose tolerance tests (GTT) were performed as previously de-
cribed (Gannon et al., 2000b) on at least three animals of each
enotype.
Western Blotting
Total pancreatic or kidney tissue from mice at 6 weeks of age
was dissected free of other organs and homogenized on ice in 30 ml
lysis buffer [10 mM Tris (pH 7.6), 10 mM NaCl, 2 mM MgCl2, 1%
Triton X-100] plus protease inhibitors (1 mM PMSF, 10 mM
leupeptin, 10 mM pepstatin A). The nuclear fraction was pelleted by
entrifugation (5 min; 500g), resuspended in 1.0 ml 13 sample
uffer [62.5 mM Tris (pH 6.8), 2% SDS, 10% glycerol], and
onicated on ice for 7 s. Following centrifugation (8 min; 14,000
pm), protein content of the supernatant was determined by com-
arison with a standard curve at 562 nm using BSA (BCA assay,
ierce). Total protein (75 mg) per lane was resolved on a 10% SDS
olyacrylamide gel and transferred to nitrocellulose by using stan-
ard methods. Membranes were stained in 0.1% Ponceau S to
s of reproduction in any form reserved.
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189Transgenic Analysis of pdx1 Regulationvisualize protein and blocked overnight at 4°C in 3% BSA in 13
blot buffer (for details, see Backstrom et al., 2000). The PDX1
antiserum was raised in rabbits against a fusion protein of GST
with the N-terminal 75 amino acids of mouse PDX1 purified from
bacteria. This antiserum detects PDX1 in tissues in an identical
pattern to b-gal expression from pdx1lacZKO (data not shown), and
pecifically recognizes PDX1 on Western blots (Macfarlane et al.,
999). Antibody incubations were in 3% BSA in blot buffer at room
emperature. The blots were incubated with primary antibodies
rabbit anti-mouse PDX1, 1:2000; rabbit anti-b-gal, 1:250; Cappel)
for 2 h, washed, and incubated with secondary antibody (alkaline
phosphatase-conjugated goat anti-rabbit, 1:1000; Dako) for 1 h.
Blots were developed with BCIP and NBT (Pierce) and scanned with
an Epson flat-bed scanner and Adobe Photoshop. Western blotting
was performed by using tissue from two different groups of mice in
four separate experiments with identical results. A representative
blot is shown.
RESULTS
Identification of pdx1 Sequences Sufficient for
Pancreatic Development
We have previously described a 14.5-kb region of DNA
spanning the pdx1 locus that was used to generate a
targeting construct for pdx1 gene inactivation (Offield et
al., 1996). This includes ;6.2 kb of sequence 59 to the open
reading frame, both exons and intron, and ;3 kb of 39
sequence (Fig. 1). Since crucial regulatory elements can be
located several kilobases 59 (Goldhamer et al., 1995) or 39 to
the coding region (Sasaki and Hogan, 1996), we used trans-
genesis to test if this 14.5-kb region contains regulatory
sequences capable of recapitulating the normal temporal
and spatial expression pattern of pdx1. We assessed the
ability of this genomic fragment to direct expression to the
endogenous pdx1 domain in two ways: transgenic rescue of
he pdx1 homozygous null phenotype and expression anal-
sis of a lacZ reporter transgene.
To attempt to rescue the null phenotype, the 14.5-kb
enomic fragment was provided as a transgene (pdx1resc) in
he pdx1lacZKO null mutant background. pdx1lacZKO is a null
llele containing lacZ within the endogenous pdx1 locus
(Offield et al., 1996). pdx12/2 neonates usually die within 1
eek of birth, lacking pancreatic tissue, but pancreatic
evelopment is essentially normal in pdx11/2 animals (Jon-
sson et al., 1994; Offield et al., 1996). Thus, pdx1 null
embryos that also carry the transgene should undergo
normal foregut and pancreatic development. Two pdx1resc
transgenic lines were generated (L1 and L2), each estimated
by Southern blot analysis to harbor two copies of the
transgene. Litters from crosses between pdx1 heterozygotes
pdx11/2) and pdx1 heterozygous mice carrying the pdx1resc
transgene (pdx11/2;pdx1resc) generated pdx12/2;pdx1resc pups
t the expected frequency of 1 in 8 for both transgenic lines.
On analysis of neonatal pdx12/2;pdx1resc mice, L1 trans-
enics showed apparently complete rescue of posterior
oregut development (Fig. 2D), and were outwardly indis-
inguishable from wild-type and heterozygous, nontrans-
Copyright © 2001 by Academic Press. All rightenic littermates (data not shown). The L2 transgene par-
ially rescued pancreas formation but failed to restore
ormal duodenal development (Figs. 2G and 2H). The
artial rescue seen in L2 may be due to the effects of
urrounding sequences at the site of integration or a failure
f the transgene to integrate intact. With the exception of
ig. 3J, therefore, the data presented are from the L1 line.
As in newborn pdx1 heterozygotes (Figs. 2B and 2C), b-gal
xpressing islet-like cell clusters were detected near the
ucts in L1 pdx12/2;pdx1resc neonates (Figs. 2E and 2F),
similar in size and shape to those present in wild-type and
pdx1 heterozygous mice. Exocrine and endocrine cells were
both present in rescued pancreata (Fig. 3), and the normal
islet architecture was observed: i.e., glucagon1, somatosta-
tin1, and PP1 cells surrounding a core of insulin1 cells (Figs.
F–3I). In addition, core islet cells showed normal expres-
ion of the b cell glucose transporter, GLUT2, at the
membrane (data not shown).
Most L2 pdx12/2;pdx1resc pups died within 1 week of
birth, similar to pdx12/2 animals, although some lived
longer than 1 week, and two survived until weaning.
Lifespan was correlated with the degree of pancreatic res-
cue. Pancreas formation in these animals varied between 10
and 30% of normal size (Figs. 2G and 2H), but differentiated
pancreatic tissue could always be identified closely apposed
to the rostral duodenum. Immunohistochemical analysis
revealed the presence of acinar cells exhibiting normal
apical/basal polarity around a central lumen (Fig. 3J), and
endocrine cells clustered into small islet-like structures
(data not shown). Currently, we believe that the pancreatic
tissue restored in the L2 mice arose from the ventral bud,
because a dorsal ductule, probably representing the devel-
opmentally arrested dorsal pancreatic bud that is seen in
pdx12/2 animals (Offield et al., 1996), was always observed
(Figs. 2G and 2H). We conclude from these data that two
independent pdx1resc transgenes can direct the formation of
all pancreatic cell types in a pdx1 null background.
pdx1 Transgene Rescues Pancreatic Function
L1 pdx12/2;pdx1resc mice were similar in body weight to
their heterozygous and wild-type siblings at weaning and at
2 months of age, and survived to adulthood (Figs. 4A and
4B). Islet morphology and architecture were also normal in
pdx12/2;pdx1resc adults (Fig. 4D). Thus, transgene-derived
dx1 expression could support pancreatic organogenesis. To
etermine whether the pdx1 transgene could restore glu-
ose homeostasis, intraperitoneal glucose tolerance tests
GTT) were performed on pdx11/2, pdx11/2;pdx1resc and
pdx12/2;pdx1resc mice to compare pancreatic function on a
ross level. These studies were undertaken to assess
hether this transgene, while sufficient for pancreatic
evelopment, nevertheless lacked regulatory elements re-
uired for aspects of pdx1 regulation in mature b cells
associated with their response to elevated blood glucose.
A representative GTT is shown in Fig. 4E. The fasting
blood glucose levels of all mice tested were in the normal
s of reproduction in any form reserved.
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190 Gannon, Gamer, and Wrightrange (below 150 mg/dl), and showed the expected in-
crease within 15 min of glucose injection. At the next
FIG. 3. All pancreatic cell types are rescued by the pdx1resc trans
neonates. Blue color, pdx1-driven lacZ expression from the pdx1lacZK
cells (E, J) is shown in brown. ins, insulin; gluc, glucagon; som, som
J: 2003.time point (30 min postinjection), blood glucose levels
Copyright © 2001 by Academic Press. All rightere beginning to return to normal for pdx11/2;pdx1 resc
(n 5 2) and pdx12/2;pdx1 resc (n 5 3) mice, while pdx11/2
. Pancreatic sections from pdx11/2 (A–E) and pdx12/2;pdx1resc (F–J)
ll allele. Immunolabeling of islet hormones (A–D, F–I) and exocrine
tatin; PP, pancreatic polypeptide; amy, amylase. A-D, F-I: 1003; E,gene
Omice (n 5 2; Fig. 4E) continued to display elevated blood
s of reproduction in any form reserved.
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191Transgenic Analysis of pdx1 RegulationFIG. 4. The pdx1resc transgene restores the normal physiological response to elevated blood glucose. Three-month-old pdx11/2;pdx1resc and
dx12/2;pdx1resc males (A) and females (B). Glucagon expression (brown) in islets from pdx11/2;pdx1resc (C) and pdx12/2;pdx1resc (D) adults is
lacZKO 2/2 rescimilar. The two copies of pdx1 in pdx1 ;pdx1 islets result in darker X-gal staining (D). (E) Glucose tolerance test showing
improved ability to clear glucose from the blood in animals carrying the pdx1resc transgene as compared to pdx11/2 mice. C, D: 1003.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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192 Gannon, Gamer, and Wrightglucose. We conclude that the pdx1 resc transgene contains
regulatory elements sufficient to direct appropriate ex-
pression of pdx1 during pancreatic development and to
support normal islet b cell function in adult mice, at least
as measured by the GTT assay. Although our current
sample size is small, glucose clearance during GTT was
similar for both pdx11/2;pdx1 resc and pdx12/2;pdx1 resc
mice, and improved compared to pdx1 heterozygotes.
To determine the relative level of PDX1 produced from
the pdx1resc transgene, Western blot analysis was performed
on pancreatic nuclear extracts by using a PDX1-specific
antiserum. This antiserum specifically recognizes a protein
at 46 kDa (Figs. 5A and 5B), the size expected for nuclear
localized PDX1 (Macfarlane et al., 1999), that was not
detected in nonexpressing tissues. In animals carrying the
pdx1lacZko allele, a specific band at ;120 kDa reacted with
DX1 (Fig. 5B) and b-gal antibodies (Fig. 5C), identifying
his band as the PDX1/b-gal fusion protein encoded by the
pdx1lacZko allele (Offield et al., 1996). The amount of PDX1/
b-gal fusion protein was increased in pdx12/2;pdx1resc ani-
FIG. 5. Western blot analysis of PDX1 expression from the
pdx1resc transgene. The antibody used is indicated to the left of each
panel. The PDX1 antiserum recognizes a specific band at 46 kDa in
pancreas and not kidney, a nonexpressing tissue (A). PDX1 protein
was detected at levels correlating with pdx1 copy number (B, upper
panel). In animals carrying the pdx1lacZKO null allele, the PDX1
antiserum also recognizes a band at approximately 120 kDa, which
represents the PDX1/b-gal fusion protein (B, middle panel). The
dentity of this protein was confirmed using an antibody against
b-gal (C). Bottom panel in (B) shows nonspecific reactivity with a
protein(s) at 100 kDa, demonstrating equal protein loading in all
lanes. Genotypes are indicated above each lane. XBKO, non-lacZ-
ontaining pdx1 null allele.mals compared to pdx11/2; pdx1resc mice. The level of PDX1
Copyright © 2001 by Academic Press. All rightenerated from the pdx1resc transgene is intermediate be-
tween that from one and two functional copies of the
endogenous pdx1 gene (Fig. 5B). As described above, this
evel of protein is sufficient to support normal pancreatic
evelopment and function. The fact that pdx1 heterozy-
otes express less PDX1 than wild-type mice demonstrates
hat expression from the remaining functional allele is not
pregulated in the heterozygous condition. The lower lev-
ls of PDX1 in pdx11/2 pancreata may be linked to the
mpaired physiological response to elevated blood glucose
bserved in these mice (Dutta et al., 1998; Ahlgren et al.,
1998; see also Fig. 4E).
Localization of pdx1 Regulatory Sequences to the
5* Region
Regulatory sequences within the 14.5-kb fragment of
pdx1 DNA were analyzed in vivo using lacZ reporter
ransgenes (Fig. 1), with b-gal expression being assayed in
mbryos, neonates, and adults. We previously showed that
he XSlacZPS transgene (Fig. 1), which contains 4.3 kb of
upstream sequence, intron, and 39 sequences, recapitulates
the endogenous pdx1 expression pattern during early em-
ryogenesis: the dorsal and ventral pancreatic buds, the
uodenum, and common bile duct (Wu et al., 1997 and see
ig. 6A). In adults, the highest levels of XSlacZPS expression
re in islet b cells, and lower levels are observed in sub-
populations of acinar cells (Wu et al., 1997). Thus, the
additional 1.9 kb of upstream sequence, which were in-
cluded in the rescue transgene construct, are not absolutely
essential to direct appropriate reporter gene expression
during embryogenesis or in the adult. These data demon-
strate that the XSlacZPS transgene contains regulatory ele-
ments sufficient to establish normal pdx1 expression dur-
ing development and in mature b cells.
The XSlacZPS transgene was then further dissected to
determine which regions were critical for directing expres-
sion to the endogenous pdx1 domain. Transgenes lacking
the 39 region (XSlacZ; data not shown), or lacking both 39 and
intronic sequences (XSchsplacZ; Fig. 6B) directed b-gal expres-
ion throughout the pdx1 domain at 11.5 d.p.c., similar to
XSlacZPS. In neonates, the XSchsplacZ transgene was expressed
at the highest levels in endocrine cells, which at this stage
of development are either found as single cells or coalesced
into primitive islets (Fig. 6B). This agreement with endog-
enous pdx1 expression was maintained in adults: highest
levels of transgene expression in b cells and lower levels in
acinar cells (data not shown). All five XSchsplacZ lines showed
he same expression pattern. All transgenes that were
xpressed in a “pdx1-like” pattern showed a sharp anterior
oundary of reporter gene activity within the antral stom-
ch epithelium and a more diffuse posterior boundary
ithin the duodenal epithelium, consistent with that seen
ith the endogenous pdx1 gene.
Intronic and 39 sequences may not contribute to pdx1
expression. For example, a transgene driven by only the 3 kb
of sequence 39 to the poly(A) tail (SphsplacZ) failed to demon-
s of reproduction in any form reserved.
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193Transgenic Analysis of pdx1 Regulationstrate any b-gal activity within the digestive tract at
11.5 d.p.c in transient transgenics. We conclude that the
4.3-kb XbaI–SacI region (Fig. 1) contains sequences suffi-
cient to direct pdx1 expression in the correct spatiotempo-
ral pattern. These results are supported by studies of Stof-
fers et al. (1999) who used a similar fragment of the pdx1
promoter to drive lacZ expression in transgenic mice.
Dissection of the pdx1 Upstream Region
Subregions of the 4.3-kb region were then tested for their
ability to drive specific patterns of expression, as summa-
rized in Fig. 1. The general hypothesis was that this region
contains separable fragments capable of directing lacZ
expression to subsets of pdx1-expressing cells, such as the
stomach or duodenal epithelium, the islet endocrine cells,
or b cells. Initially, the 4.3-kb region was divided into two
pieces, a 59 2.5-kb fragment (XbaI–XhoI) and a 39 1.8-kb
fragment (XhoI–SacI). A transgene driven by the latter
segment, XhSchsplacZ, was expressed throughout the pancre-
tic buds and duodenum at 11.5 d.p.c. (Fig. 6C). This 1.8-kb
egion is the smallest fragment so far identified that can
irect expression to essentially the entire posterior foregut
omain during embryogenesis. We have not yet tested
hether this transgene behaves similarly to the larger
SchsplacZ and endogenous pdx1 at later stages.
Identification of Endocrine-Specific Regulatory
Sequences
In dissecting the 1.8-kb XhSc fragment, we identified a
1.1-kb region (XhoI–BglII) within the 59 end that drove b-gal
expression to clusters of cells throughout the developing
pancreas, both at 14.5 d.p.c. and at postnatal day 1 (Figs. 6D
and 7). These were found to be insulin-producing cells (Figs.
7A and 7D; Table 1). At 14.5 d.p.c., the few somatostatin1
cells that were present also expressed b-gal, but at birth
only 4% of somatostatin1 cells were also b-gal1 (Table 1
and Fig. 7). The transient expression of XhBghsplacZ in soma-
ostatin1 cells may reflect their putative common origin
with b cells (Alpert et al., 1988; Teitelman et al., 1993;
osa-Pineda et al., 1997). XhBghsplacZ was not expressed in
lucagon1 cells during embryogenesis and was expressed in
only 6% of glucagon1 cells in neonates (Table 1). No
xpression from this construct was detected in any other
issue, including forming acini and duodenal epithelium,
hich normally express pdx1 at 14.5 d.p.c. Overall, expres-
ion from XhBghsplacZ is highly restricted to b cells. Some-
what surprisingly, XhBghsplacZ expression in b cells was
bsent from adult transgenics of the same line, suggesting
hat this region contributes exclusively to pdx1 expression
uring embryonic and early postnatal stages. At present, we
annot exclude the possibility that the lack of XhBghsplacZ
expression in adults does not reflect the normal activity of
this region within the endogenous locus, but rather that the
transgene becomes silenced with age. We note, however,
the absence of such silencing in any of our other transgenic n
Copyright © 2001 by Academic Press. All rightines. A transgene containing the 680 bp located at the 39
nd of the XhSc fragment (BgSchsplacZ) was not expressed in
any tissue examined from neonates and adults from two
separate lines.
In addition to the b cell-specific regulatory elements
ocated within the XhSc region, the 2.5-kb XbaI–XhoI
(XbXh) fragment (Fig. 1), also showed activity in endocrine
cell clusters at 14.5 d.p.c (Fig. 6E), with no expression in the
developing acinar pancreas, antral stomach, or rostral duo-
denum. We next tried to localize more precisely the puta-
tive endocrine cell enhancers within these two upstream
pdx1 fragments. The XbXh region was divided into a 1.5-kb
XbaI–PstI 59 fragment (XPhsplacZ) and a 1-kb PstI–BstEI 39
fragment (PBhsplacZ). Of four lines carrying the XPhsplacZ trans-
gene, only one showed expression in visceral tissue of any
type, which was localized to scattered cells within the
gastric epithelium, mainly in the antral stomach (data not
shown). The identity of these b-gal1 cells has not yet been
determined. In any case, we conclude that the 1.5-kb XP
fragment does not contain an independently acting islet-
specific regulatory element. We previously reported on the
partial characterization of the 1-kb PB region (Wu et al.,
1997; Gannon et al., 2000b). Combined with this previous
work, the present study demonstrates that this region is
capable of directing islet-specific transgene expression at
neonatal and adult stages in 10 independent lines. Here, we
have also addressed the timing and cell-type specificity of
activity from this islet enhancer. As early as 11.5 d.p.c.,
PBhsplacZ was expressed weakly in insulin- or glucagon-
roducing cells dispersed through the embryonic pancreatic
pithelium (data not shown). By 16.5 d.p.c., robust expres-
ion was detected within differentiating endocrine cells
Figs. 6F and 7). PB-driven islet expression appeared more
ntense and in a greater proportion of islet cells overall than
hat driven by the XhBg fragment located immediately
downstream. This was confirmed by quantitation follow-
ing immunohistochemical analysis, which showed that
PBhsplacZ directs expression to significant numbers of
nsulin1, glucagon1, and somatostatin1 cells during embry-
nic development and at birth (Figs. 7G–7I; Table 1). This
attern is quite different from that of the XhBghsplacZ trans-
gene, for which we detected only transient expression in
somatostatin1 cells and did not detect expression in the a
cell lineage during embryonic development (Table 1).
Dissection of b Cell-Specific Sequences
The XhBghsplacZ transgene was highly b cell-enriched and
ctive only during embryonic and perinatal stages. We
herefore attempted to narrow down the XhBg b cell-
specific activity by dividing it into two segments of 300 and
800 bp to generate the 59XhBghsplacZ and 39XhBghsplacZ trans-
enes, respectively (Figs. 1 and 8). We hypothesized that
equences that are highly conserved among vertebrate pdx1
enes (see Discussion; Gerrish et al., 2000a) were respon-
ible for the b cell-specific activity of XhBghsplacZ. In both
ewborn and adult animals, in several independent lines,
s of reproduction in any form reserved.
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atterns of expression: occasional, scattered cells (one to
everal cells per total pancreas) in ductal epithelium, acini,
FIG. 6. Transgenic analysis of pdx1 regulatory regions. The dia
genomic sequences used in transgene constructs (thick lines). Em
transgene expression is indicated by blue staining. (A, C) Lateral
Dissected digestive organs from 12.5 d.p.c. embryo. (D, E) Dissected
from 16.5 d.p.c. embryo. dpc, days post coitum; du, duodenum; vp,
one; as, antral stomach; i, intestine; s, stomach; p, pancreas.nd pancreatic blood vessels (Fig. 8). Expression was re-
Copyright © 2001 by Academic Press. All righttricted to the pancreas, but not observed in islet endocrine
ells in neonates or adults (Figs. 8C and 8F; data not shown).
n 16.5-d.p.c. embryos, the 59XhBghsplacZ transgene directed
shows the pdx1 locus (thin line and red boxes) and location of
os or digestive organs were stained with X-gal in whole mount;
s of posterior foregut staining in whole 11.5 d.p.c. embryos. (B)
tive organs from 14.5 d.p.c. embryos. (F) Dissected digestive organs
ral pancreas; dp, dorsal pancreas; sp, spinal cord; P1, postnatal daygram
bry
view
diges
ventlow levels of b-gal expression transiently to most insulin1
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ot shown). The 39XhBghsplacZ expression pattern in embryos
as equivalent to that in neonates and adults (isolated
b-gal1 cells in acinar or ductal tissue, no endocrine cell
xpression). Thus, subdivision of the XhBg region results in
loss of b cell-specific activity (see Figs. 1 and 8).
DISCUSSION
We have pursued an in vivo characterization of pdx1
regulatory sequences in the hope of focussing our future
studies on core sequences through which critical upstream
factors act on this gene. Such studies should provide valu-
able information on the position of pdx1 in a regulatory
network that is responsible for delineation of the posterior
foregut domain within the endodermal germ layer, and the
differentiation of specific organs such as the pancreas. In
addition, identifying the transcription factors regulating
FIG. 7. Comparison of XhBghsplacZ (A–F) and PBhsplacZ (G–L) expressio
slet hormones. (A) In XhBghsplacZ transgenics, all b-gal1 cells at 14.5
are b-gal1. (C) All somatostatin1 cells at 14.5 d.p.c. were also b-gal
insulin1 cells, but also in a small percentage of somatostatin1 cells (
B). The great majority of glucagon1 cells are b-gal2 at P1 (E; see T
16.5 d.p.c. (G–I), but decreases in glucagon1 cells after birth (K; see
post coitum; P, postnatal day; ins, insulin; gluc, glucagon; som, sopancreatic b cell specification, differentiation, and normal
Copyright © 2001 by Academic Press. All rightphysiology is potentially medically relevant when one
considers that dysfunction in these genes might contribute
to the development of diabetes. For example, a full under-
standing of this network might facilitate in vitro produc-
tion of islet endocrine cells, from stem or precursor cells,
for transplantation therapies (Shapiro et al., 2000).
Our transgenic analysis has identified adjacent, but sepa-
rable enhancer-like elements that are likely to be major
contributors to the normal expression of pdx1 in pancreatic
endocrine cells in vivo. Most likely, the activities of mul-
tiple factors acting in concert through these elements lead
to robust pdx1 expression within islets, and the mainte-
ance of high levels of expression specifically in b cells.
Consequently, we hypothesize that mutation of one of
several of these DNA elements, or dysfunction of the
corresponding trans-acting factor(s), might substantially
abrogate pdx1 expression and cause defects in organogen-
esis or mature organ function. A byproduct of our studies
embryos and neonates. Brown color indicates immunolabelling for
. expressed insulin (arrowheads; see Table 1); not all insulin1 cells
owhead; see Table 1). (D) At P1, XhBghsplacZ is mainly expressed in
owhead). Expression is not detected in glucagon1 cells at 14.5 d.p.c.
1). PBhsplacZ is expressed in the three islet cell types examined at
e 1). Arrowheads mark some hormone1 expressing cells. dpc, days
statin. All panels are 1003.n in
d.p.c
1 (arr
F, arr
ablehas been the generation of new tissue-specific promoter/
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196 Gannon, Gamer, and Wrightenhancer cassettes that can be used to assess the effect of
misexpressing chosen factors within the pancreas and/or
duodenum by transgenesis (Gannon et al., 2000a,b).
Compact Organization of the pdx1 Gene
Many of the essential pdx1 regulatory sequences are
located close to the coding region. A genomic fragment
spanning the coding region and 6.2 kb of sequence 59 to the
transcription start site can completely rescue the apancre-
atic pdx1 null phenotype, and maintain glucose homeosta-
sis during glucose challenge. A similar genomic region from
rat pdx1 containing 6.5 kb of upstream sequence is also able
to rescue the pdx1 homozygous null phenotype and the
glucose intolerance seen in heterozygotes (Dutta et al.,
2001). Our Western blot analysis (Fig. 5) indicates that the
steady-state level of PDX1 in pdx12/2;pdx1resc (L1) pancreata
s somewhere between that produced from one and two
ndogenous copies of pdx1, i.e., the levels in pdx11/2 and
dx11/1 mice, respectively. Because pdx11/2 mice show
TABLE 1
Quantitation of Expression from pdx-1 Islet-Specific Enhancers
e14.5 P1
XhBg 1.1-kb b cell enhancer
nsulin
bgal1 with Ins1 100% bgal1 with Ins1 88%
Ins1 with bgal1 5% Ins1 with bgal1 48%
Glucagon
bgal1 with Gluc1 0% bgal1 with Gluc1 6%
Gluc1 with bgal1 0% Gluc1 with bgal1 6%
Somatostatin
bgal1 with Som1 6% bgal1 with Som1 1%
Som1 with bgal1 100% Som1 with bgal1 4%
e16.5 P1/P2
PstBstE 1-kb islet enhancer
Insulin
bgal1 with Ins1 88% bgal1 with Ins1 62%
Ins1 with bgal1 86% Ins1 with bgal1 88%
Glucagon
bgal1 with Gluc1 32% bgal1 with Gluc1 13%
Gluc1 with bgal1 75% Gluc1 with bgal1 22%
Somatostatin
bgal1 with Som1 15% bgal1 with Som1 10%
Som1 with bgal1 85% Som1 with bgal1 57%
Note. At e14.5 and e16.5, there are likely to be some Ins1/Som1
cells accounting for the total number of bgal1 cells adding up to
more than 100%. By birth, islet lineages are segregated. PstI–BstEII
directs expression to significant numbers of the three islet cell
types examined during development and after birth. XhoI–BglII is
activity is more restricted to b cells, but is transiently active in
somatostatin cells during development, perhaps reflecting the
common lineage of b and d cells.ssentially normal pancreatic development but reduced
Copyright © 2001 by Academic Press. All rightlucose tolerance (this study; Dutta et al., 1998; Ahlgren et
l., 1998), our observations are consistent with the hypoth-
sis that the proper physiological function of b cells re-
quires a specific threshold level of PDX1.
We propose, therefore, that these compactly organized
regulatory sequences are sufficient for physiologically rel-
evant levels of PDX1 expression, including any up- and
downregulation of gene expression occurring during normal
organogenesis, or in adult pancreatic tissue. A further
delimitation of the key developmental regulatory se-
quences to a 4.3-kb (XSc) segment located immediately 59 to
exon 1 is supported by our finding, and that of Stoffers et al.
(1999), that a reporter transgene driven by these sequences
recapitulates the endogenous pdx1 expression pattern. Fu-
ture experiments will test whether this region is also
sufficient to completely rescue pancreatic development and
function in the pdx1 null background, or if additional 59
sequences contained within the rescue transgene are criti-
cal. Within the 4.3-kb region, we identified independent
DNA modules that can direct reporter gene expression to
pdx1-expressing pancreatic endocrine cells.
Separable Islet-Specific cis-Regulatory Regions in
pdx1
Currently, much attention has been focussed on the role
of pdx1 in the mature pancreas as a critical transcriptional
activator of insulin and other b cell-specific genes (see
ntroduction). Identifying the transcription factor binding
otifs required for b cell expression of pdx1 is a major goal
f our combined in vitro and in vivo analyses. Although
xperiments in endocrine cell lines have quickly yielded
nformation as to the location of potential b cell-specific
regulatory elements (Wu et al., 1997; Gerrish et al., 2000a),
a comprehensive in vivo analysis is likely to reveal how
particular elements function during embryonic and postna-
tal pancreatic development, and in adult pancreata. Our in
vivo dissection of pdx1 has identified two different islet
endocrine cell-specific pdx1 regulatory activities located in
adjacent ;1 kb fragments lying between 22.7 and 20.7 kb
upstream of exon 1 (see Fig. 9). Although these sequences
have been tested in the context of a heterologous minimal
promoter (hsp68), and we have not shown that they are
orientation/position-independent cis-regulatory sequences,
we refer to them hereafter as enhancers for simplicity.
We have already partially described the PB endocrine cell
enhancer (Wu et al., 1997; Gannon et al., 2000b). The
extended analysis presented here demonstrates that this
region directs expression to all islet endocrine cell types,
and that the proportions of a and d cells displaying reporter
gene activity vary between embryonic, neonatal, and adult
stages. The PB region can be considered a potent islet
endocrine cell enhancer, since all expressing transgenic
lines (10 of 14 total lines) showed strong endocrine-specific
activity.
In contrast to the PB endocrine-specific enhancer, an
almost exclusively b cell-specific activity was found in the
s of reproduction in any form reserved.
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197Transgenic Analysis of pdx1 Regulationadjacent XhBg fragment. This activity was transient, and
not present in adult pancreata from the same line. While
the reason for silencing of this transgene is not clear, it
suggests that the XhBg region plays a specific role in
immature b cells, or perhaps provides critical developmen-
al cues for the initiation of the mature b cell lineage and/or
FIG. 8. Transgenic dissection of the XB b cell enhancer region. Di
equences used in transgene constructs (thick lines). Construct
xpression (arrowheads) in isloated acinar (A, C, E, F) and ductal (B)
cells in 59XhBg (Area III) transgenics (D). ins, insulin; gluc, glucagonits precursors.
Copyright © 2001 by Academic Press. All rightTwo lines of evidence indicate that our transgenic find-
ings are meaningful in relation to pdx1 expression from the
endogenous chromosomal context. First, the islet (PB) and b
cell (XhBg) enhancers lie within regions of DNAse I hyper-
sensitivity that were identified in b cell lines (Wu et al.,
1997; see Fig. 9). Second, the two enhancers overlap a
shows the pdx1 locus (thin line, red box) and location of genomic
color-coded with panels below. Blue color indicates transgene
. At 16.5 d.p.c., low level b-gal expression is detected in hormone1
lets; dpc, days post coitum; P, postnatal day. A, C–H: 1003; B: 503.agram
s are
cellslocalized segment of sequence that has a high degree of
s of reproduction in any form reserved.
p
c
s
8
t
A
e
2
I
P
(
i
p
d
M
f
t
W
t
t
F
t
a
i
h
l
y
d
e
2
o
c
s
N
X
t
1
t
g
n
w
d
l
s
l
2
s
A
b
198 Gannon, Gamer, and Wrightevolutionary conservation among several vertebrates (Ger-
rish et al., 2000a; see Fig. 9), potentially indicating the
resence of core regions through which transcriptional
ontrol of pdx1 is effected.
We have divided this region of conservation into three
ubdomains—Areas I, II, and III—that show between 78 and
9% sequence conservation in blocks of 200–300 nt be-
ween human, mouse, and chick (Gerrish et al., 2000a); Fig.
9). Areas I and II are located within the PB islet enhancer,
while Area III lies at the 59 end of the XhBg b cell enhancer.
rea I or Area II can independently direct b cell-specific
xpression in cell line transfection assays (Gerrish et al.,
000a), suggesting that either the activity of Area I or Area
I may explain the islet-selective enhancer activity of the
B region in vivo.
Database analysis of Areas I, II, and III has identified
potential binding sites for endodermally expressed tran-
scription factors, including recognition sequences for the
products of other MODY genes (HNF1a, 1b, and HNF4a)
Gerrish, 2000b). This observation suggests significant
nter-regulation between MODY genes. Accordingly, it is
ossible that a mutation in one MODY gene may result in
iabetes, at least in part, by acting indirectly through other
ODY genes such as pdx1. Support for this idea comes
rom the discovery that null mutations in HNF3a or
HNF3b cause alterations in transcription of two MODY
genes, HNF1a and HNF4a, in embryonic stem cells (Dun-
can et al., 1998).
Comparison of in Vivo and in Vitro pdx1
Regulation
Valuable information on the potential regulatory activi-
ties of specific pdx1 sequences has been obtained from
FIG. 9. Diagram showing the pdx1 locus (thin line, dark gray box)
ith selected restriction enzyme sites, and genomic sequences that
irect specific patterns of transgene expression (thick lines). The
ocations of the three previously identified DNase hypersensitive
ites (HSS) are indicated above the locus (Wu et al., 1997). The
ocations of the highly conserved Areas I, II, and III (Gerrish et al.,
000a) are designated by the white boxes. Area I and Area II are
eparated by 300 bp of nonconserved sequences, while Area II and
rea III sequences are continuous and were conceptually divided
ased on their location within the PB and XB regions, respectively.ransient transfection of immortalized cell lines in vitro.
Copyright © 2001 by Academic Press. All righte tested the relevance of these sequences to pdx1 regula-
ion during organogenesis and in mature, differentiated cell
ypes by placing them in the context of the whole animal.
requently, the b cell-selective activities identified in vitro
ranslated into active elements in vivo, but this was not
lways the case. For example, the XhBg fragment, contain-
ng the conserved Area III region, overlaps a DNAse I
ypersensitive region (Fig. 9), suggesting a bona fide regu-
atory function that was confirmed in our transgenic anal-
sis. Transfection assays in cultured b cell lines, however,
id not detect cell type-selective regulatory activity in
ither XhBg (Wu et al., 1997), or Area III (Gerrish et al.,
000a). This discrepancy is, perhaps, not that surprising if
ne considers the possibility that immortalized cells have
haracteristics peculiar to a dedifferentiated or neoplastic
tate, and cannot be equated to any normal cell type in vivo.
evertheless, because the endocrine cell-specific activity of
hBg and Area III in vivo is lost by the adult stage, it is
empting to speculate that the b cell lines are more closely
related to mature b cells than embryonic cells.
Potential Redundancy in b Cell Enhancers
We have defined a genomic region that is apparently
sufficient to completely rescue the pdx1 null phenotype,
although it remains possible that a subtle physiological
function not tested here is not restored by this pdx1
transgene. This analysis is also unable to rule out the
possibility that enhancers located outside the 26.2 kb
upstream region function, in the endogenous chromosomal
context, to regulate specific aspects of pdx1 expression.
Within the 6.2-kb upstream region, we found that the
39-most 4.3 kb is capable of directing appropriate pdx1
expression throughout development and in adults, and
contains islet (PB) and b cell-specific (XhBg) enhancers.
Results from studies of rat pdx1 regulation in transfected b
cell lines suggested that another endocrine-specific en-
hancer lies at approximately 26.0 to 26.5 kb (Sharma et al.,
996, 1997). Most of this region was included in our rescue
ransgene, but was not present in the lacZ reporter trans-
enes, including those that could recapitulate the endoge-
ous pdx1 expression pattern, such as XSc and XhSc (Fig. 1).
Thus, there may be three independent regions of pdx1
that display selective activity in endocrine cells in vitro
and/or in vivo. It is possible that, in vivo, all three regions
participate in directing pdx1 expression to endocrine cells
using different batteries of transcription factors. It remains
to be seen, however, whether in vivo analysis of the 26.0 to
26.5 kb region in the mouse reveals a distinct function for
this region in regulating pdx1 expression. Establishing the
requirement for each or any of these conserved endocrine-
specific sequences in regulating this essential gene may
require deletion or mutation of specific sites within the
context of the endogenous pdx1 locus.
s of reproduction in any form reserved.
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199Transgenic Analysis of pdx1 RegulationRegional Specificity of pdx1 Expression in the
Endoderm
The finding that pdx1 is expressed within equivalent
domains of the posterior foregut endoderm in all verte-
brates so far examined implies a conserved role in the
specification and differentiation of cells, tissues, and or-
gans within this region. Our search for enhancer-like
modules that direct pdx1 expression to specific cell types
or organs has so far, however, not found sequences that
are able to direct expression exclusively to nonislet tis-
sue. Because transgenes driven by the XhSc fragment
showed activity throughout the pdx1-expression domain
(Fig. 6C), and this fragment includes the b cell-specific
XhBg enhancer, we hypothesized that separable gastric-,
duodenal-, and/or acinar-specific activities would be con-
tained within the XhSc region. The 39XhBg region, how-
ever, directed expression only to isolated acinar or ductal
cells (Fig. 8). Furthermore, the 39XhSchsplacZ transgene,
which comprises the 39XhBg sequences and the 680 bp
immediately downstream (BgSc), showed the same ex-
pression pattern as 39XhBg in embryos, neonates, and
adults (data not shown). It is unlikely that this expression
pattern is nonspecific and affected by the position of
transgene insertion, given that all expressing lines, rep-
resenting different insertion events, showed similar, al-
beit sparse, pancreas-restricted expression. Instead, we
postulate that the 39XhSc region contains elements that
are indeed important contributors to the overall pancre-
atic expression of pdx1, but that these elements were
physically separated in the construction of the transgenes
analyzed here, and act suboptimally in isolation. Simi-
larly, expression of pdx1 specifically in nonislet tissues
might require combinations of DNA segments that are
distributed throughout the XhSc region and therefore
difficult to combine selectively in one transgene con-
struct. There is precedent for cooperative interactions
between nonadjacent enhancers: in the case of HNF3b,
.5- and 0.4-kb fragments separated by 1.5 kb, drive neu-
al tube floor plate expression only in combination
Sasaki and Hogan, 1996).
When beginning our experiments, we wondered
hether negative regulatory interactions played a signif-
cant role in establishing the anterior and posterior ex-
ression boundaries of pdx1 within the developing pos-
erior foregut, and if removing such sequences would
ause expansion of reporter gene expression outside the
ndogenous pdx1 domain. However, none of the pdx1
eporter transgenes that were expressed in the stomach,
uodenum and pancreas (Fig. 1) showed altered anterior
nd posterior expression boundaries. It is possible that
epressor sequences limiting the pdx1 expression domain
ere present in all constructs tested, or that the spatio-
emporal specificity of pdx1 is established solely through
ositive-acting influences.
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